Moderna submitted its application to the US Food and Drug Administration for emergency use authorization of its updated COVID-19 vaccine booster for use in people age 18 and older the company said in a news release on Tuesday.
Local News 8's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
Moderna seeks FDA authorization for updated COVID-19 booster
Headline from Local News 8 ·
Newest
Moderna, Pfizer seek FDA authorization for updated Covid-19 vaccines; shots could be available next month
Moderna submitted its application to the US Food and Drug Administration for emergency use authorization of its updated COVID-19 vaccine booster for use in people age 18 and older the company said in a news release on Tuesday.
The reformulated booster targets the BA.5 omicron subvariant, currently dominant in the U.S. The Biden administration plans to roll out the shots in the fall.
By Carma Hassan and Brenda Goodman, CNN Moderna submitted its application to the US Food and Drug Administration for emergency use authorization of its updated Covid-19 vaccine booster for use in people age 18 and older, the company said in a news release on Tuesday.
Moderna has joined the ranks of vaccine manufacturers who have submitted a bivalent COVID-19 booster to the Food and Drug Administration for emergency use authorization as the Biden administration eyes a fall rollout for the updated shots.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Moderna seeks FDA authorization for updated COVID-19 booster | Since Then
